{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:31:24Z","timestamp":1787509884789,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mehy.2020.109862","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T11:18:02Z","timestamp":1590837482000},"page":"109862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"special_numbering":"C","title":["N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2"],"prefix":"10.1016","volume":"143","author":[{"given":"Francis L.","family":"Poe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Corn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.109862_b0005","doi-asserted-by":"crossref","DOI":"10.3345\/cep.2020.00493","article-title":"Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19)","author":"Park","year":"2020","journal-title":"Clin Exp Pediatr"},{"key":"10.1016\/j.mehy.2020.109862_b0010","doi-asserted-by":"crossref","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mehy.2020.109862_b0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.109862_b0020","article-title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses \u2013 a statement of the Coronavirus Study Group","author":"Gorbalenya","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.mehy.2020.109862_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2020.109862_b0030","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.mehy.2020.109862_b0035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fmicb.2019.00050","article-title":"Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome","volume":"10","author":"Chen","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.mehy.2020.109862_b0040","first-page":"1","article-title":"Host factors in coronavirus replication","volume":"419","author":"de Wilde","year":"2018","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.mehy.2020.109862_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.mehy.2020.109862_b0050","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.109862_b0055","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil Med Res"},{"key":"10.1016\/j.mehy.2020.109862_b0060","article-title":"The establishment of reference sequence for SARS-CoV-2 and variation analysis","author":"Wang","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.mehy.2020.109862_b0065","doi-asserted-by":"crossref","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: a storm is raging","author":"Pedersen","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2020.109862_b0070","series-title":"Features, Evaluation and Treatment Coronavirus (COVID-19)","author":"Cascella","year":"2020"},{"key":"10.1016\/j.mehy.2020.109862_b0075","doi-asserted-by":"crossref","unstructured":"Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, et al. Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19). Infectious Diseases (except HIV\/AIDS) 2020. https:\/\/doi.org\/10.1101\/2020.02.18.20024364.","DOI":"10.1101\/2020.02.18.20024364"},{"key":"10.1016\/j.mehy.2020.109862_b0080","first-page":"11","article-title":"A Review on various uses of N-acetyl cysteine","volume":"19","author":"Mokhtari","year":"2017","journal-title":"Cell J"},{"key":"10.1016\/j.mehy.2020.109862_b0085","series-title":"N Acetylcysteine","author":"Ershad","year":"2019"},{"key":"10.1016\/j.mehy.2020.109862_b0090","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1002\/jps.23325","article-title":"Interaction of N-acetylcysteine and cysteine in human plasma","volume":"101","author":"Radtke","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.mehy.2020.109862_b0095","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00262-018-2120-5","article-title":"N-acetyl cysteine protects anti-melanoma cytotoxic T cells from exhaustion induced by rapid expansion via the downmodulation of Foxo1 in an Akt-dependent manner","volume":"67","author":"Scheffel","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.mehy.2020.109862_b0100","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1089\/aid.1998.14.1589","article-title":"The role of oxidative imbalance in progression to AIDS: effect of the thiol supplier N-acetylcysteine","volume":"14","author":"Malorni","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.mehy.2020.109862_b0105","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1046\/j.1365-2362.2000.00736.x","article-title":"N-acetylcysteine replenishes glutathione in HIV infection","volume":"30","author":"De Rosa","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.mehy.2020.109862_b0110","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/1753425914566205","article-title":"The anti-inflammatory effects of acetaminophen and N-acetylcysteine through suppression of the NLRP3 inflammasome pathway in LPS-challenged piglet mononuclear phagocytes","volume":"21","author":"Liu","year":"2015","journal-title":"Innate Immun"},{"key":"10.1016\/j.mehy.2020.109862_b0115","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s41598-018-37296-x","article-title":"N-acetylcysteine modulates lipopolysaccharide-induced intestinal dysfunction","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.mehy.2020.109862_b0120","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2020.109862_b0125","doi-asserted-by":"crossref","unstructured":"Lippi G, Wong J, Henry BM. Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med 2020. https:\/\/doi.org\/10.20452\/pamw.15272.","DOI":"10.20452\/pamw.15272"},{"key":"10.1016\/j.mehy.2020.109862_b0130","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.arr.2016.01.007","article-title":"Hypertension and aging","volume":"26","author":"Buford","year":"2016","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.mehy.2020.109862_b0135","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4812","article-title":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?","author":"Patel","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2020.109862_b0140","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25785","article-title":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19","author":"Cheng","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.mehy.2020.109862_b0145","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.109862_b0150","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2147\/JIR.S141220","article-title":"Spotlight on the NLRP3 inflammasome pathway","volume":"11","author":"Groslambert","year":"2018","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.mehy.2020.109862_b0155","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.mehy.2020.109862_b0160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.mehy.2020.109862_b0165","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.4049\/jimmunol.162.4.2154","article-title":"Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases","volume":"162","author":"Aggarwal","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2020.109862_b0170","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.abb.2003.12.020","article-title":"(R)-alpha-lipoic acid reverses the age-related loss in GSH redox status in post-mitotic tissues: evidence for increased cysteine requirement for GSH synthesis","volume":"423","author":"Suh","year":"2004","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.mehy.2020.109862_b0175","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2337\/dc10-1006","article-title":"Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine","volume":"34","author":"Sekhar","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mehy.2020.109862_b0180","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3945\/ajcn.110.003483","article-title":"Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation","volume":"94","author":"Sekhar","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.mehy.2020.109862_b0185","doi-asserted-by":"crossref","unstructured":"Khomich OA, Kochetkov SN, Bartosch B, Ivanov AV. Redox Biology of Respiratory Viral Infections. Viruses 2018;10. https:\/\/doi.org\/10.3390\/v10080392.","DOI":"10.3390\/v10080392"},{"key":"10.1016\/j.mehy.2020.109862_b0190","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/sj.onc.1210796","article-title":"The cystine\/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death","volume":"27","author":"Banjac","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.mehy.2020.109862_b0195","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/10715760802317663","article-title":"Glutathione and apoptosis","volume":"42","author":"Circu","year":"2008","journal-title":"Free Radic Res"},{"key":"10.1016\/j.mehy.2020.109862_b0200","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1179\/135100009X392539","article-title":"Role of N-acetylcysteine and cystine in glutathione synthesis in human erythrocytes","volume":"14","author":"Whillier","year":"2009","journal-title":"Redox Rep"},{"key":"10.1016\/j.mehy.2020.109862_b0205","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/jn\/124.3.378","article-title":"The utilization of N-acetylcysteine and 2-oxothiazolidine-4-carboxylate by rat hepatocytes is limited by their rate of uptake and conversion to cysteine","volume":"124","author":"Banks","year":"1994","journal-title":"J Nutr"},{"key":"10.1016\/j.mehy.2020.109862_b0210","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00228-004-0850-0","article-title":"Pharmacokinetics of N-acetylcysteine following repeated intravenous infusion in haemodialysed patients","volume":"60","author":"Soldini","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.mehy.2020.109862_b0215","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0891-5849(97)00286-4","article-title":"Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes","volume":"24","author":"Samiec","year":"1998","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.mehy.2020.109862_b0220","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/jcp.1041450312","article-title":"Proliferative capacity of human peripheral blood lymphocytes sorted on the basis of glutathione content","volume":"145","author":"Kavanagh","year":"1990","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.mehy.2020.109862_b0225","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41419-018-0917-y","article-title":"SARS-Coronavirus Open Reading Frame-3a drives multimodal necrotic cell death","volume":"9","author":"Yue","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.mehy.2020.109862_b0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41420-019-0181-7","article-title":"SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes","volume":"5","author":"Shi","year":"2019","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.mehy.2020.109862_b0235","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0046-8177(03)00367-8","article-title":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore","volume":"34","author":"Franks","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.mehy.2020.109862_b0240","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1172\/JCI90699","article-title":"TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies","volume":"127","author":"McGeough","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2020.109862_b0245","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.168.9.4620","article-title":"TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection","volume":"168","author":"Roach","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2020.109862_b0250","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1165\/ajrcmb.21.4.3602","article-title":"Tumor necrosis factor-alpha mediates lipopolysaccharide-induced macrophage inflammatory protein-2 release from alveolar epithelial cells. Autoregulation in host defense","volume":"21","author":"Xavier","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.mehy.2020.109862_b0255","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1089\/ars.2009.2611","article-title":"Redox regulation of tumor necrosis factor signaling","volume":"11","author":"Han","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.mehy.2020.109862_b0260","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bcp.2011.05.014","article-title":"N-acetyl-L-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV)","volume":"82","author":"Mata","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2020.109862_b0265","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.3892\/etm.2017.4891","article-title":"Effects of N-acetylcysteine treatment in acute respiratory distress syndrome: a meta-analysis","volume":"14","author":"Zhang","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.mehy.2020.109862_b0270","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1183\/09031936.93.02030238","article-title":"Effect of N-acetylcysteine on gas exchange after methacholine challenge and isoprenaline inhalation in the dog","volume":"2","author":"Ueno","year":"1989","journal-title":"Eur Respir J"},{"key":"10.1016\/j.mehy.2020.109862_b0275","first-page":"309","article-title":"Evaluation of the effect of nebulized N-acetylcysteine on respiratory secretions in mechanically ventilated patients: randomized clinical trial","volume":"40","author":"Masoompour","year":"2015","journal-title":"Iran J Med Sci"},{"key":"10.1016\/j.mehy.2020.109862_b0280","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1164\/ajrccm.162.1.9903129","article-title":"Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice","volume":"162","author":"Hagiwara","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mehy.2020.109862_b0285","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/BCR.0b013e318198a268","article-title":"Influence of nebulized unfractionated heparin and N-acetylcysteine in acute lung injury after smoke inhalation injury","volume":"30","author":"Miller","year":"2009","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.mehy.2020.109862_b0290","doi-asserted-by":"crossref","first-page":"e13087","DOI":"10.1097\/MD.0000000000013087","article-title":"N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: a randomized controlled trial","volume":"97","author":"Zhang","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.mehy.2020.109862_b0295","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1183\/09031936.97.10071535","article-title":"Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment","volume":"10","author":"De Flora","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.mehy.2020.109862_b0300","doi-asserted-by":"crossref","DOI":"10.1097\/ALN.0000000000003296","article-title":"Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan\u2019s experience","author":"Meng","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.mehy.2020.109862_b0305","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/2045-9912.229599","article-title":"Safety and efficacy of N-acetyl-cysteine for prophylaxis of ventilator-associated pneumonia: a randomized, double blind, placebo-controlled clinical trial","volume":"8","author":"Sharafkhah","year":"2018","journal-title":"Med Gas Res"},{"key":"10.1016\/j.mehy.2020.109862_b0310","first-page":"131","article-title":"Acetaminophen-induced hepatotoxicity: a comprehensive update","volume":"4","author":"Yoon","year":"2016","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.mehy.2020.109862_b0315","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jfms.2010.09.010","article-title":"Endotracheal nebulization of N-acetylcysteine increases airway resistance in cats with experimental asthma","volume":"13","author":"Reinero","year":"2011","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.mehy.2020.109862_b0320","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/bcp.12789","article-title":"Evidence for the changing regimens of acetylcysteine","volume":"81","author":"Chiew","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.mehy.2020.109862_b0325","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(13)62062-0","article-title":"Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial","volume":"383","author":"Bateman","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.109862_b0330","unstructured":"BioSpace. New COVID-19 HOPE Clinical Trial Recommendations Introduced Today May Reduce or Eliminate Mechanical Ventilation for Coronavirus Patients | BioSpace. BioSpace 2020. https:\/\/www.biospace.com\/article\/new-covid-19-hope-clinical-trial-recommendations-introduced-today-may-reduce-or-eliminate-mechanical-ventilation-for-coronavirus-patients\/ (accessed April 10, 2020)."}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720308811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720308811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:22:58Z","timestamp":1759692178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720308811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":66,"alternative-id":["S0306987720308811"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109862","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109862"}}